Aldosterone Synthase Inhibition for Hypertension
New England Journal of Medicine · 09.10.2025 · 393 (14) · 1436-1439
DOI: 10.1056/nejme2511533 ↗Kurz gefasst
Editorial in der Zeitschrift New England Journal of Medicine, erschienen am 09.10.2025. Verfasst von Tomasz J Guzik und 1 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Cardiovascular Science, Institute of Neuroscience and Cardiovascular Research, University of Edinburgh, Edinburgh. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 9 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Centre for Cardiovascular Science, Institute of Neuroscience and Cardiovascular Research, University of Edinburgh, Edinburgh.
- Department of Internal and Agricultural Medicine, Jagiellonian University Medical College, Krakow, Poland.
- Division of Cardiovascular Sciences, Faculty of Biology, Medicine, and Health, University of Manchester, Manchester, United Kingdom.
- Manchester University National Health Service Foundation Trust, Manchester Royal Infirmary, Manchester, United Kingdom.
- Signature Research Programme in Health Services and Systems Research, Duke-National University of Singapore, Singapore.
Zitieren
APA
Guzik, T. J., & Tomaszewski, M. (2025). Aldosterone Synthase Inhibition for Hypertension. New England Journal of Medicine, 393(14), 1436-1439. https://doi.org/10.1056/nejme2511533
Vancouver
Guzik TJ, Tomaszewski M. Aldosterone Synthase Inhibition for Hypertension. New England Journal of Medicine. 2025;393(14):1436-1439. doi:10.1056/nejme2511533
BibTeX
@article{Guzik2025,
author = {Guzik, Tomasz J and Tomaszewski, Maciej},
title = {Aldosterone Synthase Inhibition for Hypertension},
journal = {New England Journal of Medicine},
year = {2025},
volume = {393},
number = {14},
pages = {1436--1439},
doi = {10.1056/nejme2511533}
}
EUVIMED